🔎 Trials Near Me

Utama › Kanser Pankreas › South Dakota

Kajian klinikal Kanser Pankreas di South Dakota

7 kajian untuk Kanser Pankreas sedang mencari peserta di lokasi di South Dakota.

Bandar di South Dakota

Teks kajian rasmi (Bahasa Inggeris)

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

  • Avera Cancer Institute Research, Sioux Falls
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Okt 2026 · NCT07562152

Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)

  • Avera Cancer Institute, Sioux Falls
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT07252232

A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

  • Investigative Site US055, Sioux Falls
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07522073

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

  • Sanford Cancer Center Oncology Clinic, Sioux Falls
  • Sanford USD Medical Center - Sioux Falls, Sioux Falls
Mengambil pesertaKajian pemerhatian
Umur 50 hingga 75 · Semua jantina · Dikemas kini 4 Sep 2026 · NCT04239573

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

  • Sanford Cancer Center Oncology Clinic, Sioux Falls
  • Sanford USD Medical Center - Sioux Falls, Sioux Falls
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT06958328

Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations

  • Rapid City Regional Hospital, Rapid City
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Mei 2026 · NCT06998940

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

  • Ohio State University Telemedicine, Rapid City
  • Ohio State University Telemedicine, Sioux Falls
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Feb 2026 · NCT06906562

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.